It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today that an independent safety monitoring committee has recommended that trials of a candidate 2009 H1N1 vaccine begin in children. NIAID concurred with this recommendation. Vaccinations will begin shortly in two trials being conducted through NIAID’s nationwide network of Vaccine and Treatment Evaluation Units (VTEU).